Update on diagnosis, treatment, and prognosis in opsoclonus–myoclonus–ataxia syndrome
- 1 December 2010
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Pediatrics
- Vol. 22 (6), 745-750
- https://doi.org/10.1097/mop.0b013e32833fde3f
Abstract
Opsoclonus–myoclonus–ataxia syndrome (OMS) is a severe autoimmune central nervous system disorder, which predominantly affects young children and causes lifelong neurological disability. Early recognition and treatment may yield better outcomes. Appreciation of the spectrum of clinical presentations of OMS, awareness of common misdiagnoses, and utilization of diagnostic criteria may facilitate the timely diagnosis of OMS. Approximately 50% of patients have an associated neuroblastoma, which may escape detection by traditional methods and require MRI or computed tomography of the torso for diagnosis. In nonparaneoplastic cases, many associated infections have been reported. Although there has been progress in autoantibody identification and cerebrospinal fluid B cell expansion is a common finding, there is no diagnostic biomarker for OMS currently. Approximately 80% of reported patients, typically treated with conventional therapies such as adrenocorticotropin hormone, corticosteroids, and/or intravenous immunoglobulin, develop long-term neurological morbidity. Newer treatment approaches using early, aggressive therapy with cyclophosphamide or rituximab are promising. The diagnosis of OMS requires a high level of suspicion and a systematic approach for diagnostic testing, particularly for neuroblastoma. Future collaborative studies are required to determine whether early, aggressive therapy will improve the typically poor long-term neurological outcome.Keywords
This publication has 46 references indexed in Scilit:
- Opsoclonus–myoclonus in children associated or not with neuroblastomaEuropean Journal of Paediatric Neurology, 2010
- A prospective study of the presentation and management of dancing eye syndrome/opsoclonus–myoclonus syndrome in the United KingdomEuropean Journal of Paediatric Neurology, 2010
- Opsoclonus myoclonus: a non-epileptic movement disorder that may present as status epilepticusArchives of Disease in Childhood, 2009
- Neurological complications of neuroblastic tumors: experience of a single centerChild's Nervous System, 2009
- Ataxia Without Opsoclonus: Right Lumbar Sympathetic Trunk NeuroblastomaClinical Pediatrics, 2008
- Paraneoplastic syndromes of the CNSThe Lancet Neurology, 2008
- An update on opsoclonusCurrent Opinion in Neurology, 2007
- Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004Cancer Letters, 2005
- Longitudinal Neurodevelopmental Evaluation of Children With Opsoclonus-AtaxiaPEDIATRICS, 2005
- Neuroepidemiologic Trends in 105 US Cases of Pediatric Opsoclonus-Myoclonus SyndromeJournal of Pediatric Oncology Nursing, 2005